Thromboembolic risk and anticoagulant therapy in COVID‐19 patients: emerging evidence and call for action

Emerging evidence shows that severe coronavirus disease 2019 (COVID‐19) can be complicated with coagulopathy, namely disseminated intravascular coagulation, which has a rather prothrombotic character with high risk of venous thromboembolism. The incidence of venous thromboembolism among COVID‐19 pat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Haematol
Autors principals: Kollias, Anastasios, Kyriakoulis, Konstantinos G., Dimakakos, Evangelos, Poulakou, Garyphallia, Stergiou, George S., Syrigos, Konstantinos
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Covid‐19
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7264537/
https://ncbi.nlm.nih.gov/pubmed/32304577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16727
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars